Chemotherapy revolutionised cancer treatment when it was first applied in the 1940s. Since then, these drugs have been refined into more selective targeted therapies.
In the regenerative medicine focus area of the ACN, researchers are developing new materials and methods to exert control over lineage determination in vitro and in vivo.
